Impact of Metabolic Syndrome on Neuroinflammation and the Blood-Brain Barrier

Overview

Journal Front Neurosci

Date 2019 Jan 9

PMID 30618559

Citations 152

Authors

Peter Van Dyken

Baptiste Lacoste

Affiliations

Soon will be listed here.

Abstract

Metabolic syndrome, which includes diabetes and obesity, is one of the most widespread medical conditions. It induces systemic inflammation, causing far reaching effects on the body that are still being uncovered. Neuropathologies triggered by metabolic syndrome often result from increased permeability of the blood-brain-barrier (BBB). The BBB, a system designed to restrict entry of toxins, immune cells, and pathogens to the brain, is vital for proper neuronal function. Local and systemic inflammation induced by obesity or type 2 diabetes mellitus can cause BBB breakdown, decreased removal of waste, and increased infiltration of immune cells. This leads to disruption of glial and neuronal cells, causing hormonal dysregulation, increased immune sensitivity, or cognitive impairment depending on the affected brain region. Inflammatory effects of metabolic syndrome have been linked to neurodegenerative diseases. In this review, we discuss the effects of obesity and diabetes-induced inflammation on the BBB, the roles played by leptin and insulin resistance, as well as BBB changes occurring at the molecular level. We explore signaling pathways including VEGF, HIFs, PKC, Rho/ROCK, eNOS, and miRNAs. Finally, we discuss the broader implications of neural inflammation, including its connection to Alzheimer's disease, multiple sclerosis, and the gut microbiome.

Citing Articles

Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders.

Ozer E, Keskin A, Berrak Y, Cankara F, Can F, Gursoy-Ozdemir Y Discov Ment Health. 2025; 5(1):18.

PMID: 39987419 PMC: 11846830. DOI: 10.1007/s44192-025-00128-2.

Predicting neurocognitive decline in older persons living with VIH: a spotlight on the T-CD4 + /CD8 + ratio.

Serrano-Villar S, Moreno S Eur Geriatr Med. 2025; 16(1):315-316.

PMID: 39954033 DOI: 10.1007/s41999-024-01144-1.

Liraglutide and denatonium benzoate attenuate T2DM-induced metabolic, neurological, and testicular changes in rats: Targeting oxidative stress, inflammation, and BCRP transporter.

Harby S, Fathelbab M, Nawwar B, Sheta E, Halwag D, Elneily D J Mol Histol. 2025; 56(2):78.

PMID: 39881033 DOI: 10.1007/s10735-025-10355-0.

Studying targeted oxidation in diabetic cognitive dysfunction based on scientometrics analysis: research progress of natural product approaches.

Tu W, Xu F, Li J, Tian X, Cao L, Wang L Front Endocrinol (Lausanne). 2025; 15():1445750.

PMID: 39758348 PMC: 11695123. DOI: 10.3389/fendo.2024.1445750.

The Role of Hypothalamic Microglia in the Onset of Insulin Resistance and Type 2 Diabetes: A Neuro-Immune Perspective.

Darwish R, Alcibahy Y, Bucheeri S, Albishtawi A, Tama M, Shetty J Int J Mol Sci. 2024; 25(23).

PMID: 39684879 PMC: 11642714. DOI: 10.3390/ijms252313169.

References

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

Proescholdt M, Heiss J, Walbridge S, Muhlhauser J, Capogrossi M, Oldfield E . Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999; 58(6):613-27. DOI: 10.1097/00005072-199906000-00006. View

Patti M, Virkamaki A, Landaker E, Kahn C, Yki-Jarvinen H . Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes. 1999; 48(8):1562-71. DOI: 10.2337/diabetes.48.8.1562. View

Feng Y, Seibler J, Alami R, Eisen A, Westerman K, Leboulch P . Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J Mol Biol. 1999; 292(4):779-85. DOI: 10.1006/jmbi.1999.3113. View

Duelli R, Maurer M, Staudt R, Heiland S, Duembgen L, Kuschinsky W . Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res. 2000; 858(2):338-47. DOI: 10.1016/s0006-8993(00)01942-9. View

Mayhan W . Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res. 2000; 866(1-2):101-8. DOI: 10.1016/s0006-8993(00)02254-x. View

Badr G, Tang J, Ismail-Beigi F, Kern T . Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes. 2000; 49(6):1016-21. DOI: 10.2337/diabetes.49.6.1016. View

Burguera B, Couce M, Curran G, Jensen M, Lloyd R, Cleary M . Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes. 2000; 49(7):1219-23. DOI: 10.2337/diabetes.49.7.1219. View

Yancopoulos G, Davis S, Gale N, Rudge J, Wiegand S, Holash J . Vascular-specific growth factors and blood vessel formation. Nature. 2000; 407(6801):242-8. DOI: 10.1038/35025215. View

10.

Hickey M, Hutchison J, Michaud J, Sutcliffe I, Kubes P . A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circ Res. 2000; 87(12):1141-8. DOI: 10.1161/01.res.87.12.1141. View

11.

Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A . Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol. 2000; 20(12):E120-6. DOI: 10.1161/01.atv.20.12.e120. View

12.

Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun C . Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001; 98(5):2604-9. PMC: 30185. DOI: 10.1073/pnas.041359198. View

13.

Matarese G, Di Giacomo A, Sanna V, Lord G, Howard J, Di Tuoro A . Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol. 2001; 166(10):5909-16. DOI: 10.4049/jimmunol.166.10.5909. View

14.

Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A . Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001; 21(11):3740-8. PMC: 6762728. View

15.

Matarese G, Sanna V, Di Giacomo A, Lord G, Howard J, Bloom S . Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol. 2001; 31(5):1324-32. DOI: 10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y. View

16.

Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B . Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001; 293(5539):2449-52. DOI: 10.1126/science.1062688. View

17.

Treins C, Giorgetti-Peraldi S, Murdaca J, Van Obberghen E . Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem. 2001; 276(47):43836-41. DOI: 10.1074/jbc.M106534200. View

18.

Fischer S, Wobben M, Marti H, Renz D, Schaper W . Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2001; 63(1):70-80. DOI: 10.1006/mvre.2001.2367. View

19.

Vlassara H, Palace M . Diabetes and advanced glycation endproducts. J Intern Med. 2002; 251(2):87-101. DOI: 10.1046/j.1365-2796.2002.00932.x. View

20.

Chen J, Braet F, Brodsky S, Weinstein T, Romanov V, Noiri E . VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am J Physiol Cell Physiol. 2002; 282(5):C1053-63. DOI: 10.1152/ajpcell.00292.2001. View